PMID: 11920765Mar 29, 2002Paper

Poly(lactide-co-glycolide) microspheres for the controlled release of oligonucleotide/polyethylenimine complexes

Journal of Pharmaceutical Sciences
Giuseppe De RosaElias Fattal

Abstract

In this article, microspheres able to induce the controlled release of oligonucleotide/polyethylenimine complexes are proposed. A model oligonucleotide (the oligothymidilate pdT16) was encapsulated within poly(lactide-co-glycolide) microspheres alone or associated with polyethylenimine (PEI) at different nitrogen/phospate (N/P) ratios. Microspheres were prepared by the multiple emulsion-solvent evaporation technique and characterized for morphology, diameter, encapsulation efficiency, and release kinetics. The introduction of PEI in the internal aqueous phase resulted in the formation of a soluble complex with pdT16 and in a strong increase of the oligonucleotide encapsulation efficiency. PEI affected microsphere morphology inducing the formation of very porous particles yielding to an accelerated release of pdT16. When incubated with HeLa cells, microspheres encapsulating pdT16/PEI complexes allowed both a reduction of the complex toxicity and an improvement of the intracellular penetration of the released oligonucleotide. We conclude that biodegradable microspheres encapsulating oligonucleotides/PEI complexes have a great potential as controlled release system because they allow the sustained release of an oligonucleotide car...Continue Reading

References

Apr 1, 1991·Proceedings of the National Academy of Sciences of the United States of America·J P LeonettiB Lebleu
Sep 1, 1991·Proceedings of the National Academy of Sciences of the United States of America·S AgrawalJ Y Tang
Nov 1, 1982·The Journal of Pharmacy and Pharmacology·A T Florence, D Whitehill
Aug 1, 1995·Proceedings of the National Academy of Sciences of the United States of America·O BoussifJ P Behr
Sep 1, 1993·Bioconjugate Chemistry·J Haensler, F C Szoka
Jul 30, 1999·Journal of Controlled Release : Official Journal of the Controlled Release Society·W T GodbeyA G Mikos
Jan 19, 2000·Trends in Pharmacological Sciences·K J Myers, N M Dean
Feb 22, 2000·Journal of Drug Targeting·G F LemkineB A Demeneix
Jun 6, 2000·Advanced Drug Delivery Reviews·B DemeneixJ Remy
Jun 7, 2000·European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Für Pharmazeutische Verfahrenstechnik E.V·I LebedevaM Vilenchik
Oct 6, 2000·Journal of Controlled Release : Official Journal of the Controlled Release Society·T FreytagR Bodmeier
May 1, 1992·Trends in Cell Biology·S Akhtar, R L Juliano

❮ Previous
Next ❯

Citations

Oct 6, 2007·Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan·Kohei TaharaYoshiaki Kawashima
Oct 28, 2010·Expert Opinion on Drug Delivery·Giuseppe De RosaAldo Galeone
Jul 29, 2003·Journal of Pharmaceutical Sciences·Melanie A Lysik, Susanna Wu-Pong
Aug 28, 2012·European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Für Pharmazeutische Verfahrenstechnik E.V·J PrésumeyG De Rosa
May 4, 2010·Biomaterials·Morten Ø AndersenKenneth A Howard
Feb 2, 2010·European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences·Jenny HoGareth M Forde
Oct 23, 2008·International Journal of Pharmaceutics·Yogesh Patil, Jayanth Panyam
May 13, 2008·Journal of Controlled Release : Official Journal of the Controlled Release Society·Amit RawatFakhrul Ahsan
Sep 25, 2007·International Journal of Pharmaceutics·Christopher M SpringateHelen M Burt
Jul 23, 2008·Biotechnology and Bioengineering·Jenny HoGareth M Forde
Aug 14, 2012·The Journal of Pharmacy and Pharmacology·Francesca UngaroFabiana Quaglia
Nov 14, 2006·Advanced Drug Delivery Reviews·Elias Fattal, Amélie Bochot
Jun 30, 2006·European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences·Francesca UngaroMaria Immacolata La Rotonda
Apr 29, 2006·Journal of Controlled Release : Official Journal of the Controlled Release Society·Ana L Gomes dos SantosElias Fattal
Jan 31, 2012·European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Für Pharmazeutische Verfahrenstechnik E.V·Annalisa DalmoroMatteo d'Amore
Jul 6, 2004·Molecular Therapy : the Journal of the American Society of Gene Therapy·Angela K Pannier, Lonnie D Shea
Nov 19, 2005·Expert Review of Medical Devices·Jae-Hyung JangLonnie D Shea
May 26, 2004·International Journal of Pharmaceutics·E FattalA Bochot
Dec 14, 2007·Journal of Biomedical Materials Research. Part B, Applied Biomaterials·Y RamgopalW T Godbey
Nov 1, 2018·Current Medicinal Chemistry·Fei HaoJing Xie
Jan 28, 2015·Journal of Materials Chemistry. B, Materials for Biology and Medicine·Olivier CoulembierRichard Hoogenboom
Jul 16, 2008·Soft Matter·Owen R DaviesSnow Stolnik
Mar 24, 2020·Wiley Interdisciplinary Reviews. Nanomedicine and Nanobiotechnology·Zhibo YuElias Fattal
Jun 25, 2005·Artificial Cells, Blood Substitutes, and Immobilization Biotechnology·Yong SunFujun Wang
Feb 22, 2021·International Journal of Pharmaceutics·Serra GürcanElias Fattal
Jun 19, 2008·Langmuir : the ACS Journal of Surfaces and Colloids·Owen R DaviesSnjezana Stolnik
May 26, 2021·Advanced Drug Delivery Reviews·Elias Fattal, François Fay

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.